1. Cell Death Mechanisms in Esophageal Squamous Cell Carcinoma Induced by Vesicular Stomatitis Virus Matrix Protein
   Yousef Douzandegan et al, 2019, Osong Public Health Res Perspect CrossRef
2. Artificial Life and Therapeutic Vaccines Against Cancers that Originate in Viruses
   María Elena Escobar-Ospina et al, 2019 CrossRef
3. Recent Advances in Molecular Mechanisms of the NKG2D Pathway in Hepatocellular Carcinoma
   Jian Wang et al, 2020, Biomolecules CrossRef
4. The potential use of oncolytic viruses in breast cancer: historical aspects and future prospects (literature review)
   Dmitriy A Morozov et al, 2019, J. Mod. Onco. CrossRef
5. Simultaneous Tumor and Stroma Targeting by Oncolytic Viruses
   Anne Everts et al, 2020, Biomedicines CrossRef
6. Combination Therapy of Novel Oncolytic Adenovirus with Anti-PD1 Resulted in Enhanced Anti-Cancer Effect in Syngeneic Immunocompetent Melanoma Mouse Model
   Mariangela Garofalo et al, 2021, Pharmaceutics CrossRef
7. Oncolytic Viruses in Combination Therapeutic Approaches with Epigenetic Modulators: Past, Present, and Future Perspectives
   Annalisa Chianese et al, 2021, Cancers CrossRef
8. Stability and Hopf Bifurcation Analysis of an Oncolytic Virus Infection Model with Two Time Delays and Saturation Incidence
   Xia Liu et al, 2022, Mathematical Problems in Engineering CrossRef
9. Immune checkpoint inhibitors for PD-1/PD-L1 axis in combination with other immunotherapies and targeted therapies for non-small cell lung cancer
   Ofek Mussafi et al, 2022, Front. Oncol. CrossRef
10. Role of mucoadhesive agent in ocular delivery of ganciclovir microemulsion: cytotoxicity evaluation in vitro and ex vivo
    Manisha Choudhari et al, 2022, Int Ophthalmol CrossRef
11. The Clinical Advances of Oncolytic Viruses in Cancer Immunotherapy
    Mohammed A Zolaly et al, 2023 CrossRef